abstract
Bioactive glass scaffolds are used in bone and tissue biomedical implants, and there is great interest in their fabrication by additive manufacturing/3D printing techniques, such as robocasting. Scaffolds need to be macroporous with voids >= 100 mu m to allow cell growth and vascularization, biocompatible and bioactive, with mechanical properties matching the host tissue (cancellous bone for bone implants), and able to dissolve/resorb over time. Most bioactive glasses are based on silica to form the glass network, with calcium and phosphorous content for new bone growth, and a glass modifier such as sodium, the best known being 45S5 Bioglass(R). 45S5 scaffolds were first robocast in 2013 from melt-quenched glass powder. Sol-gel-synthesized bioactive glasses have potential advantages over melt-produced glasses (e.g., greater porosity and bioactivity), but until recently were never robocast as scaffolds, due to inherent problems, until 2019 when high-silica-content sol-gel bioactive glasses (HSSGG) were robocast for the first time. In this review, we look at the sintering, porosity, bioactivity, biocompatibility, and mechanical properties of robocast sol-gel bioactive glass scaffolds and compare them to the reported results for robocast melt-quench-synthesized 45S5 Bioglass(R)scaffolds. The discussion includes formulation of the printing paste/ink and the effects of variations in scaffold morphology and inorganic additives/dopants.
keywords
MECHANICAL-PROPERTIES; PHOSPHATE SCAFFOLDS; MICROSTRUCTURE; CERAMICS; BEHAVIOR; SYSTEM
subject category
Engineering
authors
Ben-Arfa, BAE; Pullar, RC
our authors
Basam Abobaker Emhmed Ben-Arfa
Researcher
Rob Pullar
Collaboratoracknowledgements
R. C. Pullar was funded by the FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) grant number IF/00681/2015. This research was funded by, and this work was developed within the scope of, the project CICECO-Aveiro Institute of Materials, UIDB/50011/2020 & UIDP/50011/2020, financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement.